This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (7)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

H2-Receptor Blockade in Gastrointestinal Disease

William Schlippert, MD

Arch Intern Med. 1978;138(8):1257-1260.

Abstract
Cimetidine is an H2-receptor antagonist that is capable of marked suppression of gastric acid and pepsin secretion. Patients with active duodenal ulcer disease treated with cimetidine show improved rates of healing and symptom relief compared with placebo-treated controls. Peptic ulcer and diarrhea of Zollinger-Ellison syndrome and other acid hypersecretory states respond to cimetidine treatment, as may stress ulcers and steatorrhea of patients with pancreatic insufficiency who have a suboptimal response to oral pancreatin. Effectiveness with gastric ulcer has been less convincing than with duodenal ulcer. In duodenal ulcer disease, cimetidine need not replace less expensive antacid therapy in most cases and is unlikely to replace definitive surgery for suitable candidates.

(Arch Intern Med 138:1257-1260, 1978)

Author Affiliations
From the Division of Gastroenterology, Department of Medicine, University of Iowa Hospitals, Iowa City.

Footnotes
Accepted for publication Feb 3, 1978.

Reprint requests to Division of Gastroenterology, Department of Medicine, University of Iowa Hospital, Iowa City, IA 52242 (Dr Schlippert).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?